The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins
Open accessAbstract
squamous cell carcinoma antigen 1 or 2 α1 antitrypsin (α1 proteinase inhibitor) α2 antiplasmin amyloid-β α1 antichymotrypsin antithrombin III monocyte-neutrophil elastase inhibitor ovalbumin plasminogen activator inhibitor type 1 or 2 pigment epithelium-derived factor vascular endothelial growth factor reactive site loop tissue plasminogen activator urokinase plasminogen activator The serpins (serineproteinase inhibitors) are a superfamily of proteins (350–500 amino acids in size) that fold into a conserved structure and employ a unique suicide substrate-like inhibitory mechanism. The serpins were last reviewed in 1994 (1Potempa J. Korzus E. Travis J. J. Biol. Chem. 1994; 269: 15957-15960Abstract Full Text PDF PubMed Google Scholar). More recent studies show: 1) an expanded distribution within the kingdoms of metazoa and plantae, as well as certain viruses, 2) a surprising effect on the covalently bound target proteinase, and 3) novel biochemical and biological functions. Most serpins inhibit serine proteinases of the chymotrypsin family. However, cross-class inhibitors have been identified. The viral serpin CrmA and, to a lesser extent, PI9 (SERPINB9) inhibit the cysteine proteinase, caspase 1 (2Komiyama T. Ray C.A. Pickup D.J. Howard A.D. Thornberry N.A. Peterson E.P. Salvesen G. J. Biol. Chem. 1994; 269: 19331-19337Abstract Full Text PDF PubMed Google Scholar), and SCCA11 (SERPINB3) neutralizes the potent papain-like cysteine proteinases, cathepsins L, K, and S (3Schick C. Pemberton P.A. Shi G.-P. Kamachi Y. Cataltepe S. Bartuski A.J. Gornstein E.R. Bromme D. Chapman H.A. Silverman G.A. Biochemistry. 1998; 37: 5258-5266Crossref PubMed Scopus (259) Google Scholar). In addition, several members no longer function as proteinase inhibitors but perform other roles such as hormone transport (thyroid-binding globulin (SERPINA6), corticosteroid-binding globulin (SERPINA7)), and blood pressure regulation (angiotensinogen (SERPINA8)) (1Potempa J. Korzus E. Travis J. J. Biol. Chem. 1994; 269: 15957-15960Abstract Full Text PDF PubMed Google Scholar). Data base searching provides evidence for ∼500 serpins, with full-length coding sequences known or predicted for about one-half of those (4Irving J.A. Pike R.N. Lesk A.M. Whisstock J.C. Genome Res. 2000; 10: 1845-1864Crossref PubMed Scopus (523) Google Scholar). A phylogenetic analysis divides serpins into 16 clades (see Supplemental Data, Table A) and 10 highly diverged “orphans” (4Irving J.A. Pike R.N. Lesk A.M. Whisstock J.C. Genome Res. 2000; 10: 1845-1864Crossref PubMed Scopus (523) Google Scholar). These data facilitate the construction of a consistent expandable nomenclature (see Supplemental Data for Serpin Nomenclature Guidelines, Table B). The completed DNA sequences of several organisms have yielded insight into the complexity of the family. The Caenorhabditis elegans, Drosophila melanogaster, and Arabidopsis thalianagenomes encode for ∼20,000, 13,000, and 25,000 genes, respectively. However, these three species harbor ∼9, 32, and 13 serpin genes, respectively. The nonlinear relationship among the number of serpin genes, relative to the total gene number, suggests that at least a subset of serpins has evolved divergent functions despite a striking degree of sequence and structural conservation. Serpins adopt a metastable conformation that is required for their inhibitory activity (5Stein P.E. Carrell R.W. Nat. Struct. Biol. 1995; 2: 96-113Crossref PubMed Scopus (398) Google Scholar). This conformation consists of a conserved secondary structure comprised of β-sheets A, B, and C and at least 7 α-helices (most typically have 9, lettered A–I; Fig.1 A). The RSL, which contains the proteinase recognition site, is an exposed, flexible stretch of ∼17 residues tethered between β-sheets A and C. Serpins can undergo major structural rearrangements that involve alternative conformations for the RSL, β-sheet A, and the attached strand 1 of β-sheet C. Considering only intramolecular structural changes, serpins can convert to the more stable latent form (Fig. 1 B). The RSL inserts into the middle of β-sheet A to give a fully antiparallel β-sheet, and s1C is extracted from β-sheet C to provide an exposed “return” from the bottom of the serpin. Serpins in the latent conformation are noninhibitory but can be converted back to the active state by denaturation and refolding. The Tm for unfolding of latent PAI1 (SERPINE1) is 17 °C higher than that for the native state (reviewed in Ref. 6Gettins P.G.W. Patston P.A. Olson S.T. Serpins: Structure, Function and Biology, Molecular Biology Intelligence Unit. R. G. Landes Co., and Chapman & Hall, Austin, TX1996Google Scholar). The most stable state for inhibitory serpins is the RSL-cleaved form, in which the RSL has fully inserted into β-sheet A, as in the latent conformation, but without the need to extract s1C from β-sheet C (Fig. 1 C). Estimates of the Tm for unfolding of such conformations are >120 °C, compared with ∼60 °C for the
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H.-J., Benedict, W., & Bouck, N. P. (1999) · Science · doi:10.1126/science.285.5425.245 · Cited by 1,505
Structure of a serpin–protease complex shows inhibition by deformation
Huntington, J. A., Read, R. J., & Carrell, R. W. (2000) · Nature · doi:10.1038/35038119 · Cited by 1,093
Self-citationMaspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial Cells
Zou, Z., Anisowicz, A., Hendrix, M. J. C., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., & Sager, R. (1994) · Science · doi:10.1126/science.8290962 · Cited by 912
The serpin superfamily of proteinase inhibitors: structure, function, and regulation.
Potempa, J., Korzus, E., & Travis, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33954-6 · Cited by 875
Self-citationIrving, J. A., Pike, R. N., Lesk, A. M., & Whisstock, J. C. (2000) · Genome Research · doi:10.1101/gr.147800 · Cited by 598
Self-citationMaspin is an angiogenesis inhibitor
Zhang, M., Volpert, O., Shi, Y. H., & Bouck, N. (2000) · Nature Medicine · doi:10.1038/72303 · Cited by 456
Constitutive Activation of Toll-Mediated Antifungal Defense in Serpin-Deficient Drosophila
Levashina, E. A., Langley, E., Green, C., Gubb, D., Ashburner, M., Hoffmann, J. A., & Reichhart, J.-M. (1999) · Science · doi:10.1126/science.285.5435.1917 · Cited by 436
Antiangiogenic Activity of the Cleaved Conformation of the Serpin Antithrombin
O'Reilly, M. S., Pirie-Shepherd, S., Lane, W. S., & Folkman, J. (1999) · Science · doi:10.1126/science.285.5435.1926 · Cited by 432
What do dysfunctional serpins tell us about molecular mobility and disease?
Stein, P. E., & Carrell, R. W. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0295-96 · Cited by 414
Self-citationFamilial dementia caused by polymerization of mutant neuroserpin
Davis, R. L., Shrimpton, A. E., Holohan, P. D., Bradshaw, C., Feiglin, D., Collins, G. H., Sonderegger, P., Kinter, J., Becker, L. M., Lacbawan, F., et al. (1999) · Nature · doi:10.1038/43894 · Cited by 356
Self-citationKomiyama, T., Ray, C. A., Pickup, D. J., Howard, A. D., Thornberry, N. A., Peterson, E. P., & Salvesen, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32171-3 · Cited by 351
Self-citationSchick, C., Pemberton, P. A., Shi, G.-P., Kamachi, Y., Çataltepe, S., Bartuski, A. J., Gornstein, E. R., Brömme, D., Chapman, H. A., & Silverman, G. A. (1998) · Biochemistry · doi:10.1021/bi972521d · Cited by 284
Self-citationNeuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis
Yepes, M., Sandkvist, M., Wong, M. K. K., Coleman, T. A., Smith, E., Cohan, S. L., & Lawrence, D. A. (2000) · Blood · doi:10.1182/blood.v96.2.569 · Cited by 278
Inhibitory conformation of the reactive loop of α1-antitrypsin
Elliott, P. R., Lomas, D. A., Carrell, R. W., & Abrahams, J. P. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-676 · Cited by 242
Self-citationPlasminogen Activator Inhibitor Type 2 Inhibits Tumor Necrosis Factor α-induced Apoptosis
Dickinson, J. L., Bates, E. J., Ferrante, A., & Antalis, T. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27894 · Cited by 228
Hastings, G. A., Coleman, T. A., Haudenschild, C. C., Stefansson, S., Smith, E. P., Barthlow, R., Cherry, S., Sandkvist, M., & Lawrence, D. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33062 · Cited by 217
Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1
Stefansson, S., Petitclerc, E., Wong, M. K., McMahon, G. A., Brooks, P. C., & Lawrence, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007609200 · Cited by 177
Serpins: Structure, Function and Biology
Gettins, P. G. W., Patston, P. A., & Olson, S. T. (1996) · Medical Entomology and Zoology · Cited by 167
Self-citationSerine proteinase inhibitors from nematodes and the arms race between host and pathogen
Zang, X., & Maizels, R. M. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01761-8 · Cited by 149
Grigoryev, S. A., Bednář, J., & Woodcock, C. L. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5626 · Cited by 113
Kaslik, G., Kardos, J., Szabó, E., Szilágyi, L. S., Závodszky, P., Westler, W. M., Markley, J. L., & Gráf, L. (1997) · Biochemistry · doi:10.1021/bi962931m · Cited by 95
Characterization of Cucurbita maxima Phloem Serpin-1 (CmPS-1)
Yoo, B.-C., Aoki, K., Xiang, Y., Campbell, L. R., Hull, R. J., Xoconostle‐Cázares, B., Monzer, J., Lee, J., Ullman, D. E., & Lucas, W. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006060200 · Cited by 94
Plasminogen activator inhibitor type 2 in breast cancer
Duggan, C. R., Kennedy, S., Kramer, M., Barnes, C., Elvin, P., McDermott, E. W. M., O’Higgins, N. J., & Duffy, M. J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.435 · Cited by 67
Regulation of pro‐apoptotic leucocyte granule serine proteinases by intracellular serpins
Bird, P. I. (1999) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1999.00787.x · Cited by 63
Self-citationJensen, P. H., Schüler, E., Woodrow, G., Richardson, M., Goss, N. H., Højrup, P., Petersen, T. E., & Rasmussen, L. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36619-x · Cited by 62
Riewald, M., & Schleef, R. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14526 · Cited by 26
Human Proteinase Inhibitor 9 (PI9) Is a Potent Inhibitor of Subtilisin A
Dahlen, J. R., Foster, D. C., & Kisiel, W. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7282 · Cited by 20
Cited by
Lysosomal membrane permeabilization in cell death
Boya, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.310 · Cited by 1,426
Targeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
Serpin Structure, Mechanism, and Function
Gettins, P. G. W. (2002) · Chemical Reviews · doi:10.1021/cr010170+ · Cited by 1,226
Self-citationSchell, M. A., Karmirantzou, M., Snel, B., Vilanova, D., Berger, B., Pessi, G., Zwahlen, M.-C., Desiere, F., Bork, P., Delley, M., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212527599 · Cited by 948
Cell-mediated immunity in arthropods: Hematopoiesis, coagulation, melanization and opsonization
Jiravanichpaisal, P., Lee, B. L., & Söderhäll, K. (2006) · Immunobiology · doi:10.1016/j.imbio.2005.10.015 · Cited by 870
Metadata
- Authors
- Silverman, G. A., Bird, P. I., Carrell, R. W., Church, F. C., Coughlin, P. B., Gettins, P. G. W., Irving, J. A., Lomas, D. A., Luke, C. J., Moyer, R. W., Pemberton, P. A., Remold-O'Donnell, E., Salvesen, G. S., Travis, J., & Whisstock, J. C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 276
- Issue
- 36
- Pages
- 33293-33296
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2171215167
- Cited by
- 1,230
- References
- 27
- FWCI
- 21.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.